VRQOL in Cataract Patients During the COVID-19 Pandemic

Senile Cataract Clinical Trial

Official title:

Assessment of Vision-related Quality of Life (VRQOL) in Cataract Patients During the COVID-19 Pandemic

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04468308
• Other study ID #: VRQOL Cataract COVID-19
• Status: Recruiting
• Start date: September 8, 2020
• Est. completion date: March 2021

Study information

• Verified date: June 2020
• Source: Medical University Innsbruck
• Contact: Teresa Rauchegger, Dr.
• Phone: +43 512 504 23721
• Email: teresa.rauchegger[@]i-med.ac.at
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of this questionnaire survey is to evaluate the improvement in vision-related quality of life before and after cataract surgery using the National Eye Institute Visual Function Questionnaire 25 and the delay of improvement in the COVID-19 pandemic.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 116
• Est. completion date: March 2021
• Est. primary completion date: March 2021
• Gender: All
• Age group: 50 Years and older

Eligibility

Inclusion Criteria:

• Age = 50 years

• Senile cataract

• Indication for unilateral or bilateral cataract surgery

• Postponed cataract surgery due to the COVID-19 pandemic

• Signed and dated declaration of consent

Exclusion Criteria:

• Complex form of cataract (traumatic cataract, secondary cataract after intraocular inflammation)

• Amblyopia on the eye that is to be operated on

• Severe, visually impairing eye disease on the eye that is to operated on

• Known dementia or memory problems

Related Conditions & MeSH terms

• Cataract
• Senile Cataract

Intervention

Other:
• Questionnaire
Patients complete the National Eye Institute Visual Function Questionnaire 25 pre-operative, 1 month and 3 month postoperatively.

Locations

Country	Name	City	State
Austria	Medical University Innsbruck	Innsbruck	Tyrol

Sponsors (1)

Lead Sponsor	Collaborator
Medical University Innsbruck

Country where clinical trial is conducted

Austria, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Improvement Vision-related quality of life	Extent of improvement of vision-related qualitiy of life due to cataract surgery measured with the National Eye Institut Visual Function Questionnaire 25.	3 months
Secondary	Delay of Vision-related quality of life	Delay of improvement of vision-related qualitiy of life in the COVID-19 pandemic measured in days between the originally scheduled operation and the actual operation date	3 months
Secondary	Visual acuity	Visual acuity difference between visual acuity at the time of indication for cataract surgery, on the day of surgery and one month postoperatively.	1 month